SPARC gene homepage

General information
Gene symbol SPARC
Gene name secreted protein, acidic, cysteine-rich (osteonectin)
Chromosome 5
Chromosomal band q31-q33
Imprinted Unknown
Genomic reference NC_000005.9
Transcript reference NM_003118.3
Associated with diseases OI-17
Citation reference(s) -
Curators (1) LOVD-team, but with Curator vacancy
Total number of public variants reported 0
Unique public DNA variants reported 0
Individuals with public variants 0
Hidden variants 0
Date created May 03, 2013

Links to other resources
HGNC 11219
Entrez Gene 6678
PubMed articles SPARC
OMIM - Gene 182120
OMIM - Diseases OI-17 (osteogenesis imperfecta, type XVII (OI-17))


Active transcripts


ID     

Chr     

Name     

NCBI ID     

NCBI Protein ID     

DescendingVariants     
00020100 5 secreted protein, acidic, cysteine-rich (osteonectin) NM_003118.3 NP_003109.1 0


Copyright & disclaimer
The contents of this LOVD database are the intellectual property of the respective curator(s). Any unauthorised use, copying, storage or distribution of this material without written permission from the curator(s) will lead to copyright infringement with possible ensuing litigation. Copyright © 2013-2019. All Rights Reserved. For further details, refer to Directive 96/9/EC of the European Parliament and the Council of March 11 (1996) on the legal protection of databases.

We have used all reasonable efforts to ensure that the information displayed on these pages and contained in the databases is of high quality. We make no warranty, express or implied, as to its accuracy or that the information is fit for a particular purpose, and will not be held responsible for any consequences arising out of any inaccuracies or omissions. Individuals, organisations and companies which use this database do so on the understanding that no liability whatsoever either direct or indirect shall rest upon the curator(s) or any of their employees or agents for the effects of any product, process or method that may be produced or adopted by any part, notwithstanding that the formulation of such product, process or method may be based upon information here provided.